Assessing the prognostic value of transcriptomic data in multiple myeloma through machine learning methodologies. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract ...
Effect of TT-816, a novel immune response modifier targeting cannabinoid CB2 receptor, on antitumor immunity and cancer growth. Antitumor mechanisms of OncoTherad (MRB-CFI-1) nanoimmunotherapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results